What departments does Alnylam Pharmaceuticals have?

Alnylam Pharmaceuticals has employees across 11 departments including Finance, Operations, Legal, Business Development, Engineering.

What is the largest department at Alnylam Pharmaceuticals?

The largest department at Alnylam Pharmaceuticals is Finance with 3 employees.

Where are Alnylam Pharmaceuticals employees located globally?

Alnylam Pharmaceuticals has employees across 7 continents and 38 countries including Egypt, Algeria, Nigeria, India, Japan.

How has Alnylam Pharmaceuticals's team size changed over time?

Alnylam Pharmaceuticals's team has decreased from approximately 2.7K to 2.7K employees based on available data.

Alnylam Pharmaceuticals Employee Directory

Biotechnology ResearchMassachusetts, United States1001-5000 Employees

Alnylam Pharmaceuticals, based in Cambridge, Massachusetts, is an independent biopharmaceutical company focused on RNA interference (RNAi) therapeutics. It aims to silence disease-causing genes to treat a range of conditions, including both rare and prevalent diseases, with its first RNAi therapy approved in 2018. The company operates on a global scale with offices across North America, Europe, Asia, and South America and an international workforce. Its products are designed for patients and the healthcare system, and the company pursues partnerships to broaden access, including a June 2026 expansion of its collaboration with Genesis Pharma Group in Europe. Within the biotech industry, Alnylam is positioned as a pioneer in RNAi therapeutics, continuing development across indications and maintaining active engagement in the field.

Alnylam Pharmaceuticals Global Highlights

North America
2.7K

United States Of America
2.7K
Canada
15
Mexico
1
Haiti
1

Europe
450

United Kingdom Of Great Britain And Northern Ireland
143
Switzerland
61
Netherlands
58
Germany
54
Spain
39
Italy
36
France
26
Portugal
8
Austria
7
Sweden
6
Belgium
4
Ireland
2
Romania
1
Poland
1
Luxembourg
1
Denmark
1
Greece
1
Finland
1

Asia
72

Japan
44
India
12
Saudi Arabia
9
United Arab Emirates
4
Iran
1
China
1
Syrian Arab Republic
1

South America
30

Brazil
28
Chile
1
Paraguay
1

Africa
5

Egypt
3
Algeria
1
Nigeria
1

Oceania
1

Australia
1

Alnylam Pharmaceuticals's Leadership

D. C.
Chief Executive Officer
Mobile Phone
Email
V. R.
Chief Financial Officer
Mobile Phone
Email
D. J.
Chief Financial Officer
Mobile Phone
Email
J. H.
Chief Operating Officer
Mobile Phone
Email
P. H.
Chief Ethics & Compliance Officer
Mobile Phone
Email
S. M.
Chief Development Officer
Mobile Phone
Email
S. C.
Chief Technology Officer
Mobile Phone
Email
M. L.
Vp - Clinical Research
Mobile Phone
Email

Alnylam Pharmaceuticals Employee Metrics

100%

50%

0%

2026

2025

Research
Business
Operations
Engineering
Analytics
Other
Quality Assurance
Biotechnology
Sales
Legal
Administrative
Community & Social Services

Contact profiles from Alnylam Pharmaceuticals

Name

Title

Contact

Location

Last Update

E. G.
Vice President Global Commercial Fp&a, Global Forecasting & International Finance
Mobile Phone
Email
Spain, Community of Madrid
Aug 11, 2026
C. P.
Senior Vice President, Head Of Pipeline Delivery
Mobile Phone
Email
United Kingdom, England
Sep 09, 2026
C. C.
Vice President - Medical Affairs, Global Rare Lead
Mobile Phone
Email
Italy
Apr 14, 2026
C. G. K.
Svp, Value And Pipeline Commercialization
Mobile Phone
Email
United Kingdom
Apr 21, 2026
L. D.
Vp, Head Of Medical Affairs, Partner & Emerging Markets
Mobile Phone
Email
Brazil, São Paulo
Oct 07, 2026
B. M.
Svp General Manager, Uk & Ireland And Cemea Commercial Innovation Lead
Mobile Phone
Email
United Kingdom, England
Sep 15, 2026
J. M.
Vp Head Of International Regulatory Affairs
Mobile Phone
Email
United Kingdom, England
Sep 08, 2026
J. W.
Head Of Ethics & Compliance / France & Germany
Mobile Phone
Email
Germany
Oct 13, 2026
A. M.
Senior Director | Intl. Market Access - Head Of Northern Europe (uk, Ireland, Nordics), Canada
Mobile Phone
Email
United Kingdom, United Kingdom
Sep 19, 2026
B. M.
Vp, Head Of Medical Affairs, International Ttr
Mobile Phone
Email
Apr 21, 2026

Frequently Asked Questions

What is Alnylam Pharmaceuticals known for?

Alnylam Pharmaceuticals was founded in 2002 and operates in the Biotechnology Research industry. You can contact Alnylam Pharmaceuticals's main corporate office by phone at

+1-617-551-****

. Explore Alnylam Pharmaceuticals's company overview page for more information.

What is Alnylam Pharmaceuticals's most common email format?

Alnylam Pharmaceuticals employees' email format typically follows the pattern of FLast@alnylam.com. Trying to find reliable and up-to-date employee contact data? Find more Alnylam Pharmaceuticals email formats with LeadIQ.

How many employees does Alnylam Pharmaceuticals have currently?

Alnylam Pharmaceuticals has approximately 3.1K employees as of October 2026. These team members are located across 6 continents, including North America, Europe and Asia.

Who are Alnylam Pharmaceuticals's key employees and leadership?

As of October 2026, Alnylam Pharmaceuticals's key employees include:

Chief Executive Officer: D. C.
Chief Financial Officer: V. R.
Chief Financial Officer: D. J.
Chief Operating Officer: J. H.
Chief Ethics & Compliance Officer: P. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Alnylam Pharmaceuticals Employee Directory

Find Alnylam Pharmaceuticals employees' phone numbers or email addresses

Name search is limited — try advanced search instead